CLASS II ONGOING Device recall · Reported 28 Feb 2024 · FDA Enforcement Report

Synapse Cardiology PACS V7.3.0, V7.2, V7.1, V7.0 recalled

Fujifilm Healthcare Americas is recalling Synapse Cardiology PACS V7.3.0, V7.2, V7.1, V7.0, distributed nationwide in the US. The recall was initiated on 3 Jan 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI 854904006008 Software versions 7.3.000, 7.2.200, 7.2.100, 7.2.000, 7.1.000, 7.0.000
Quantity recalled13

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1171-2024
FDA event ID
93855
Recalling firm
Fujifilm Healthcare Americas, Lexington, MA
Classification
Class II
Status
Ongoing
Recall initiated
3 Jan 2024
FDA classified
21 Feb 2024
Reported
28 Feb 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

3 Jan 2024Recall initiated by company
21 Feb 2024Classified by FDA+49 days
28 Feb 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The LV Mass (2D Bullet) equation may be calculated incorrectly, resulting in a variance in the mass of the left ventricle (LV Mass). If used as a main factor for diagnosis, there is a risk of misdiagnosis or incorrect treatment plan of a patient, resulting in long-term health consequences or serious deterioration of health.

Product as listed by the FDA

Synapse Cardiology PACS V7.3.0, V7.2, V7.1, V7.0. A web-based application as the primary user interface for the processing of medical images.

Where it was distributed

US domestic distribution nationwide. International distribution to Israel.

Nationwide

Questions about this recall

Why was it recalled?

The LV Mass (2D Bullet) equation may be calculated incorrectly, resulting in a variance in the mass of the left ventricle (LV Mass). If used as a main factor for diagnosis, there is a risk of misdiagnosis or incorrect treatment plan of a patient, resulting in long-term health consequences or serious deterioration of health.

Which lots are affected?

UDI-DI 854904006008 Software versions 7.3.000, 7.2.200, 7.2.100, 7.2.000, 7.1.000, 7.0.000

Where was it sold?

US domestic distribution nationwide. International distribution to Israel.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 93855
ReportedClassRecallCompanyReasonWhere
CLASS IISynapse CV with AR recalled by FUJIFILM Healthcare AmericasFujifilm Healthcare AmericasOtherNationwide

More recalls from Fujifilm Healthcare Americas

All 24

Other Other Medical Devices recalls

All 13,778